Long-term Outcomes of Patients with Embolic Stroke of Undetermined Source According to Subtype

Overview

Journal Sci Rep

Specialty Science

Date 2024 Apr 23

PMID 38653743

Authors

Il Hyung Lee

JoonNyung Heo

Hyungwoo Lee

Jaewook Jeong

Joonho Kim

Minho Han

Joonsang Yoo

Jinkwon Kim

Minyoul Baik

Hyungjong Park

Jae Wook Jung

Young Dae Kim

Hyo Suk Nam

Affiliations

Soon will be listed here.

Abstract

The prognosis of patients with embolic stroke of undetermined source (ESUS) may vary according to the underlying cause. Therefore, we aimed to divide ESUS into subtypes and assess the long-term outcomes. Consecutive patients with acute ischemic stroke who underwent a comprehensive workup, including transesophageal echocardiography and prolonged electrocardiography monitoring, were enrolled. We classified ESUS into minor cardioembolic (CE) ESUS, arteriogenic ESUS, two or more causes ESUS, and no cause ESUS. Arteriogenic ESUS was sub-classified into complex aortic plaque (CAP) ESUS and non-stenotic (< 50%) relevant artery plaque (NAP) ESUS. A total of 775 patients were enrolled. During 1286 ± 748 days follow-up, 116 major adverse cardiovascular events (MACE) occurred (4.2 events/100 patient-years). Among the ESUS subtypes, CAP ESUS was associated with the highest MACE frequency (9.7/100 patient-years, p = 0.021). Cox regression analyses showed that CAP ESUS was associated with MACE (hazard ratio 2.466, 95% confidence interval 1.305-4.660) and any stroke recurrence (hazard ratio 2.470, 95% confidence interval, 1.108-5.508). The prognosis of ESUS varies according to the subtype, with CAP ESUS having the worst prognosis. Categorizing ESUS into subtypes could improve patient care and refine clinical trials.

References

Diener H, Sacco R, Easton J, Granger C, Bernstein R, Uchiyama S . Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019; 380(20):1906-1917. DOI: 10.1056/NEJMoa1813959. View

Kamel H, Longstreth Jr W, Tirschwell D, Kronmal R, Broderick J, Palesch Y . The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2018; 14(2):207-214. PMC: 6645380. DOI: 10.1177/1747493018799981. View

Hart R, Catanese L, Perera K, Ntaios G, Connolly S . Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update. Stroke. 2017; 48(4):867-872. DOI: 10.1161/STROKEAHA.116.016414. View

Nam H, Kim H, Kim Y, Lee H, Kim J, Lee D . Long-term mortality in patients with stroke of undetermined etiology. Stroke. 2012; 43(11):2948-56. DOI: 10.1161/STROKEAHA.112.661074. View

Blackshear J, Pearce L, Hart R, Zabalgoitia M, Labovitz A, Asinger R . Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke. 1999; 30(4):834-40. DOI: 10.1161/01.str.30.4.834. View

Nam H, Han S, Lee J, Ahn S, Ha J, Rim S . Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology. 2006; 67(7):1184-8. DOI: 10.1212/01.wnl.0000238511.72927.3c. View

Lee B, Nam H, Heo J, Kim D . Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis. 2001; 12(3):145-51. DOI: 10.1159/000047697. View

Shang Z, Tao L, Li X, Yang B, Ntaios G, Chen H . The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high-resolution imaging. Eur J Neurol. 2022; 29(9):2654-2663. DOI: 10.1111/ene.15409. View

Tsivgoulis G, Katsanos A, Kohrmann M, Caso V, Lemmens R, Tsioufis K . Embolic strokes of undetermined source: theoretical construct or useful clinical tool?. Ther Adv Neurol Disord. 2019; 12:1756286419851381. PMC: 6535711. DOI: 10.1177/1756286419851381. View

10.

Diener H, Easton J, Granger C, Cronin L, Duffy C, Cotton D . Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source.... Int J Stroke. 2015; 10(8):1309-12. DOI: 10.1111/ijs.12630. View

11.

Chatzikonstantinou A, Ebert A, Schoenberg S, Hennerici M, Henzler T . Atherosclerosis in intracranial, extracranial, and coronary arteries with aortic plaques in patients with ischemic stroke of undetermined etiology. Int J Neurosci. 2014; 125(9):663-70. DOI: 10.3109/00207454.2014.961188. View

12.

Song T, Kim Y, Yoo J, Kim J, Chang H, Hong G . Association between Aortic Atheroma and Cerebral Small Vessel Disease in Patients with Ischemic Stroke. J Stroke. 2016; 18(3):312-320. PMC: 5066433. DOI: 10.5853/jos.2016.00171. View

13.

Ntaios G, Pearce L, Meseguer E, Endres M, Amarenco P, Ozturk S . Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. Stroke. 2019; 50(11):3184-3190. DOI: 10.1161/STROKEAHA.119.025813. View

14.

Tao L, Li X, Hou X, Yang B, Xia C, Ntaios G . Intracranial Atherosclerotic Plaque as a Potential Cause of Embolic Stroke of Undetermined Source. J Am Coll Cardiol. 2021; 77(6):680-691. DOI: 10.1016/j.jacc.2020.12.015. View

15.

Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K . Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis. Stroke. 2014; 46(1):176-81. DOI: 10.1161/STROKEAHA.114.007240. View

16.

Ntaios G, Vemmos K, Lip G, Koroboki E, Manios E, Vemmou A . Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. Stroke. 2016; 47(9):2278-85. DOI: 10.1161/STROKEAHA.116.013713. View

17.

Hart R, Sharma M, Mundl H, Shoamanesh A, Kasner S, Berkowitz S . Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial. Eur Stroke J. 2019; 1(3):146-154. PMC: 6301240. DOI: 10.1177/2396987316663049. View

18.

Hart R, Diener H, Coutts S, Easton J, Granger C, ODonnell M . Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-38. DOI: 10.1016/S1474-4422(13)70310-7. View

19.

Ueno Y, Tateishi Y, Doijiri R, Kuriki A, Shimizu T, Kikuno M . Large aortic arch plaques correlate with CHADS and CHADS-VASc scores in cryptogenic stroke. Atherosclerosis. 2019; 284:181-186. DOI: 10.1016/j.atherosclerosis.2019.03.009. View

20.

Kleindorfer D, Towfighi A, Chaturvedi S, Cockroft K, Gutierrez J, Lombardi-Hill D . 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021; 52(7):e364-e467. DOI: 10.1161/STR.0000000000000375. View